Joe Ibrahim
Impact in
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
-
- Cancer Genomics and Diagnostics
Papers in
-
- Epigenetics and DNA Methylation 12
- RNA modifications and cancer 7
- Heme Oxygenase-1 and Carbon Monoxide 2
- Inflammasome and immune disorders 2
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Ken Op de Beeck (13 shared papers)Guy Van Camp (13 shared papers)Marc Peeters (9 shared papers)Erik Fransén (5 shared papers)Lieselot Croes (3 shared papers)Patrick Pauwels (3 shared papers)Wim Vanden Berghe (6 shared papers)Arvid Suls (3 shared papers)
- Journals
- Clinical Epigenetics (4 papers)Cancers (2 papers)British Journal of Cancer (1 paper)Acta Neuropathologica Communications (1 paper)Molecular Oncology (1 paper)
- Partner nations
- BelgiumLebanonUnited States
In The Last Decade
Joe Ibrahim
22 papers receiving 471 citations
Peers
Comparison fields: 5 of 75
- Nephrology 66
- Cancer Research 95
- Molecular Biology 378
- Immunology 100
- Pulmonary and Respiratory Medicine 85
Countries citing papers authored by Joe Ibrahim
This map shows the geographic impact of Joe Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joe Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joe Ibrahim more than expected).
Fields of papers citing papers by Joe Ibrahim
This network shows the impact of papers produced by Joe Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joe Ibrahim. The network helps show where Joe Ibrahim may publish in the future.
Co-authors
The 25 scholars most cited alongside Joe Ibrahim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 91 | |
| 2 | 2020 | 72 | |
| 3 | 2019 | 64 | |
| 4 | 2022 | 63 | |
| 5 | 2021 | 32 | |
| 6 | 2019 | 28 | |
| 7 | 2022 | 26 | |
| 8 | 2016 | 18 | |
| 9 | 2020 | 18 | |
| 10 | 2016 | 11 | |
| 11 | 2023 | 10 | |
| 12 | 2024 | 9 | |
| 13 | 2020 | 7 | |
| 14 | 2016 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2025 | 5 | |
| 17 | 2024 | 3 | |
| 18 | 2025 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2013 | 2 |
About Joe Ibrahim
Joe Ibrahim is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Pulmonary and Respiratory Medicine and Oncology, having authored 23 papers that have together received 479 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (12 papers), RNA modifications and cancer (7 papers), Cancer Genomics and Diagnostics (4 papers), Ferroptosis and cancer prognosis (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers), Inflammasome and immune disorders (2 papers) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Nephrology (66 citations), Cancer Research (95 citations), Molecular Biology (378 citations), Immunology (100 citations) and Pulmonary and Respiratory Medicine (85 citations). Joe Ibrahim has collaborated with scholars based in Belgium, Lebanon and United States. Frequent co-authors include Ken Op de Beeck, Guy Van Camp, Marc Peeters, Erik Fransén, Lieselot Croes, Patrick Pauwels, Wim Vanden Berghe, Arvid Suls, Matthias Beyens and Peter Vandenabeele. Their work appears in journals such as Clinical Epigenetics, Cancers, British Journal of Cancer, Acta Neuropathologica Communications and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.